know your
body

Discover new horizons in medical diagnostics and actively optimise the health of your patients.

Combyn BioCore Monitor

Innovative technologies for the medicine of tomorrow

Our forward-looking technology combines many medical methods and enables a fully automated examination in less than 5 minutes – the effort is identical to that of a 12-lead ECG.
Your patients enjoy the greatest possible comfort, while you receive the findings immediately after the measurement and in a clearly structured form.
learn more

The examination yields health data on:

Autonomic nervous system

  • Physiological and pathological circulatory data simultaneously and without additional effort during the 12-lead ECG
  • Haemodynamic monitoring (e.g. with a tilt table)
  • Sympathetic activity

Heart

  • Screening for chronic heart failure
  • Prediction of the hormone BNP
  • Estimation of cardiac output
  • 12-lead ECG

Circulation

  • Prediction of physical performance
  • Blood pressure measurement (oscillometric)
  • Pulse wave velocity
  • Vascular stiffness
  • Screening for peripheral arterial disease (PAD)

Fluid balance

  • Total body water (TBW)
  • Overhydration
  • Intracellular water (ICF)
  • Extracellular water (ECF)
  • Detection of oedema

Muscle and body fat

  • Appendicular muscle mass
  • Detection of sarcopenia
  • Determination of “dry” muscle mass (taking ECF into account and correcting for it)
  • Body fat
  • Abdominal fat

Risk assessments

  • Osteoporosis
  • Diabetes

Validated technology combined in a single device

The Combyn BioCore Monitor combines proven, scientifically validated methods in a single device.
Body analysis in 6 segments – precise measurement of muscle mass, water distribution and perfusion
Body analysis in 6 segments – precise measurement of muscle mass, water distribution and perfusion
The combined model of plethysmographic flow signal and ECF analysis reliably predicts elevated BNP values (>400 pg/ml) – an established marker for heart failure.
The combined model of plethysmographic flow signal and ECF analysis reliably predicts elevated BNP values (>400 pg/ml) – an established marker for heart failure.
Averaged segmental plethysmograms (“templates”) show the time-shifted arrival of the volume pulses in the thorax, arms and legs – including the detection of asymmetries.
Averaged segmental plethysmograms (“templates”) show the time-shifted arrival of the volume pulses in the thorax, arms and legs – including the detection of asymmetries.
Low measuring frequencies capture only extracellular water (ECF); high frequencies penetrate the cell membrane and also capture intracellular water (ICF). This allows fluid status to be determined segmentally and in a differentiated way.
Low measuring frequencies capture only extracellular water (ECF); high frequencies penetrate the cell membrane and also capture intracellular water (ICF). This allows fluid status to be determined segmentally and in a differentiated way.
A generally elevated ECF/TBW or ECF/ICF ratio indicates subclinical heart failure. Side-to-side differences point to unilateral oedema (e.g. thrombosis).
A generally elevated ECF/TBW or ECF/ICF ratio indicates subclinical heart failure. Side-to-side differences point to unilateral oedema (e.g. thrombosis).
Only the corrected muscle mass index reliably shows sarcopenia in heart failure – a central parameter for risk stratification.
Only the corrected muscle mass index reliably shows sarcopenia in heart failure – a central parameter for risk stratification.
Volume wave velocity is markedly elevated in patients with coronary artery disease – an indication of increased vascular stiffness.
Volume wave velocity is markedly elevated in patients with coronary artery disease – an indication of increased vascular stiffness.
With extrasystoles, blood delivery is markedly reduced – clearly visible in the plethysmogram.
With extrasystoles, blood delivery is markedly reduced – clearly visible in the plethysmogram.
Overstretched cardiac muscle fibres reduce actin–myosin interaction – BNP release and blood acceleration behave inversely.
Overstretched cardiac muscle fibres reduce actin–myosin interaction – BNP release and blood acceleration behave inversely.
Previous
Next

Optimize your
processes

Reduce the time required for examinations and thereby increase the efficiency of your practice workflows

Request a quote

Your added value

Greater efficiency in everyday practice

Transform your practice with our multifunctional BioCore Monitor and provide more efficient patient care.

learn more

Your benefits at a glance:

Space saving

Replace 11 devices with 1 device and create more space in your practice.

Cost saving

Reduce equipment and staff costs considerably.

Competitive advantage

The cost of an examination for patients is reduced by up to 90 % – a major competitive advantage.

Medical expertise

Scientifically grounded methods – developed by doctors.

Expanded diagnostic options

Offer your patients expanded diagnostic options.

Shorter waiting times

Make your practice more attractive to your patients by shortening examination times.

Faster results

Considerable time savings compared with individual examinations, thanks to the combination of several methods in one device.

Medical expertise

With decades of experience and a highly qualified team of doctors, we are setting new standards in preventive medicine.

about us

Univ. Prof. Dr Falko Skrabal,
Medical Advisor

Portrait of CEO Christoph

Dr Christoph Grimmer,
CEO

Our partners

We work together with renowned institutions to guarantee the highest medical standards. Through these partnerships, the Combyn BioCore Monitor benefits from scientific expertise, innovative research and practice-oriented development.

Enquire now

Ready to take your practice to the next level with the Combyn BioCore Monitor?

Join a network of leading doctors and institutions who are already using our innovative technology successfully – to optimise patient care together. Get in touch to test the Combyn BioCore Monitor or to request a quote.

Request a quote
Combyn™Test the BioCore Monitor

Careers

Shape the future of medical technology with us

We are looking for committed professionals who want to move the healthcare sector forward together with us. Discover your career opportunities!
to careers
Speculative application

Open positions

News & articles

View all
With the Combyn ECG we bring preventive healthcare to where people are – simple, efficient and with real added value for companies and their customers.
Dr Christoph Grimmer
CEO